Depression affects older adults at measurable rates, but reported prevalence varies by study design and region. In the United States, 6.0% of adults aged 60 and older reported major depressive disorder in a 2019 to 2020 population based study. Worldwide estimates suggest depressive symptoms in older adults can reach 13.3%, and Europe estimates run as high as 17.4%, with persistent treatment gaps and high cost burdens behind much of the ongoing impact.
Key Takeaways
- 6.0% of adults aged 60+ reported major depressive disorder in a 2019–2020 population-based study in the United States
- 5.0% prevalence of late-life depression (age 65+) is estimated for the United States in a 2023 review
- 35% prevalence of depressive symptoms among older adults is reported as an estimate in a 2021 global review of late-life depression epidemiology
- In a 2020 health economics study, tele-mental health for older adults reduced travel costs by 65% versus in-person care
- A 2022 study estimated that indirect costs (lost productivity/caregiving) from depression for older adults were $8.9 billion annually in the U.S.
- A 2020 review reported that psychotherapy plus pharmacotherapy reduced total healthcare costs by 7% compared with usual care in older adults
- 1 in 3 older adults with depression remains untreated due to barriers such as cost and stigma in a 2020 review (barrier prevalence estimate)
- 30% of older adults with depression receive inadequate treatment (coverage/quality estimate) in a WHO 2021 report on mental health care gaps
- In the U.S., about 4 in 10 adults aged 65+ with major depression receive no treatment (estimate from NHIS-based analysis)
- Collaborative care reduced symptom severity by 0.32 SD (standardized mean difference) in a 2021 systematic review in older adults
- Measurement-based care improved depression outcomes by 0.25 SD in a 2020 meta-analysis (older adults and late-life)
- In a 2022 survey of healthcare AI adoption, 18% of organizations reported using AI for mental health screening or triage
- In a 2020 study, PHQ-9 score reduction of 5 points was achieved in 52% of older adults after 12 weeks of treatment (clinical response)
- In a 2019 diagnostic accuracy study, PHQ-9 sensitivity for major depression in older adults was 0.83 and specificity was 0.78
- In a 2020 trial, computerized depression screening improved follow-up appointment completion by 1.4x among older adults
About 6% of US adults aged 60 plus report major depression, and many remain untreated.
Related reading
01 · Category
Prevalence & Burden9 stats
01
6.0% of adults aged 60+ reported major depressive disorder in a 2019–2020 population-based study in the United States
02
5.0% prevalence of late-life depression (age 65+) is estimated for the United States in a 2023 review
03
35% prevalence of depressive symptoms among older adults is reported as an estimate in a 2021 global review of late-life depression epidemiology
04
13.3% prevalence of depressive symptoms among older adults worldwide (estimate) reported in a 2020 systematic review/meta-analysis
05
17.4% prevalence of depression among older adults in Europe (estimate) reported in a 2019 systematic review
06
9.7% point prevalence of depression among people aged 60+ in a 2019 WHO-supported multi-country study using ICD-based measures
07
Depression and anxiety disorders contribute 6.4% of years lived with disability (YLDs) globally in the WHO Global Health Estimates 2021 (all ages)
08
In the Global Burden of Disease 2019 study, depressive disorders ranked as the third leading cause of disability for adults aged 70+
09
Globally, an estimated 1 in 8 adults aged 60+ has a mental disorder (including depression) in a 2021 WHO fact sheet
Interpretation
Prevalence & Burden Interpretation
Across studies and regions, depression burden in older adults is typically reported in the mid to high single digits for clinical depression but rises to around one in three for depressive symptoms, with prevalence estimates ranging from 5.0% late-life depression in the US to 35% depressive symptoms globally.
02 · Category
Cost & Economics14 stats
01
In a 2020 health economics study, tele-mental health for older adults reduced travel costs by 65% versus in-person care
02
A 2022 study estimated that indirect costs (lost productivity/caregiving) from depression for older adults were $8.9 billion annually in the U.S.
03
A 2020 review reported that psychotherapy plus pharmacotherapy reduced total healthcare costs by 7% compared with usual care in older adults
04
In a 2019 budget impact analysis, depression treatment programs reduced hospitalization costs by 12% among older adults (modeled)
05
In a 2021 study, depression was associated with an average increase of 0.3 hospital admissions per year among older adults
06
In a 2021 cost-effectiveness analysis, collaborative care for late-life depression had an incremental cost-effectiveness ratio (ICER) of $18,000per QALY gained (base case)
07
In a 2020 study, depression in older adults increased annual out-of-pocket spending by $420on average
08
$13.7 billion annual cost burden attributable to depression in older adults (estimated direct healthcare costs) in a 2022 economic analysis
09
In a 2022 payer analysis, claims for older adults with depression were 1.7 times higher than controls across all-cause spending
10
A 2019 modeling study estimated that scaling up depression screening and treatment in older adults would be cost-saving within 5 years in the U.K. health system
11
$5.0 billion in annual Medicare spending is attributed to depression care for beneficiaries aged 65+ in a 2020 estimate
12
In a 2021 study, nursing home residents with depression had an average length of stay increase of 0.4 days per admission
13
A 2022 report estimated that mental health conditions cost the U.S. economy $282.1 billion in 2019 (depression included), according to the National Academies mental health cost framework
14
In a 2021 global burden cost model, depression in older adults accounts for 3.0% of total health system costs attributable to non-communicable diseases (model output)
Interpretation
Cost & Economics Interpretation
Across cost and economics evidence, depression care for older adults looks increasingly cost-saving or cost-effective, with tele-mental health cutting travel costs by 65% and psychotherapy plus pharmacotherapy reducing total healthcare costs by 7%, while modeled treatment programs also lower hospitalization costs by 12%.
03 · Category
Care Access & Treatment4 stats
01
1 in 3 older adults with depression remains untreated due to barriers such as cost and stigma in a 2020 review (barrier prevalence estimate)
02
30% of older adults with depression receive inadequate treatment (coverage/quality estimate) in a WHO 2021 report on mental health care gaps
03
In the U.S., about 4 in 10 adults aged 65+ with major depression receive no treatment (estimate from NHIS-based analysis)
04
In a 2022 study, 28% of older adults with depression had psychotherapy within 3 months (claims-based)
Interpretation
Care Access & Treatment Interpretation
Across studies, roughly 1 in 3 older adults with depression do not get treatment due to barriers like cost and stigma, and even when they reach care, about 30% receive inadequate treatment, meaning that under the Care Access & Treatment category the gap is both large and persistent.
More related reading
04 · Category
Industry Trends & Adoption4 stats
01
Collaborative care reduced symptom severity by 0.32 SD (standardized mean difference) in a 2021 systematic review in older adults
02
Measurement-based care improved depression outcomes by 0.25 SD in a 2020 meta-analysis (older adults and late-life)
03
In a 2022 survey of healthcare AI adoption, 18% of organizations reported using AI for mental health screening or triage
04
In a 2023 vendor landscape report, 60+ vendors offer depression screening tools integrated into EHR platforms (count of vendors)
Interpretation
Industry Trends & Adoption Interpretation
Industry adoption is accelerating as AI-based mental health screening reaches 18% of organizations and EHR-integrated depression screening tools expand to 60+ vendors, while evidence also shows that measurement-based and collaborative care improve depression outcomes by 0.25 to 0.32 SD in older adults.
05 · Category
Screening & Diagnostics7 stats
01
In a 2020 study, PHQ-9 score reduction of 5 points was achieved in 52% of older adults after 12 weeks of treatment (clinical response)
02
In a 2019 diagnostic accuracy study, PHQ-9 sensitivity for major depression in older adults was 0.83 and specificity was 0.78
03
In a 2020 trial, computerized depression screening improved follow-up appointment completion by 1.4x among older adults
04
In a 2019 study, clinician documentation of depression severity (e.g., PHQ-9/GDS) was present in 66% of visits after implementing measurement-based care
05
The Healthy Aging Program cited in a 2022 report screened 1.2 million older adults for depression using standardized tools (U.S. program reach)
06
In a 2021 randomized trial of collaborative care for late-life depression, depression remission occurred in 41% of participants in the intervention vs 26% in usual care (adjusted comparison)
07
In the U.S., Medicare annual wellness visits include depression screening when clinically appropriate (CMS guidance effective during 2024)
Interpretation
Screening & Diagnostics Interpretation
Across Screening & Diagnostics in older adults, PHQ 9 shows solid diagnostic performance with 0.83 sensitivity and 0.78 specificity, and when screening is put into practice it can measurably improve outcomes such as 52% achieving a 5 point PHQ 9 reduction after 12 weeks and collaborative care reaching 41% remission.
06 · Category
Health Outcomes3 stats
01
In a 2019 meta-analysis, late-life depression was associated with 1.7x higher risk of stroke (pooled risk ratio)
02
1.5x higher risk of frailty in older adults with depression is reported in a 2019 meta-analysis (pooled OR/RR)
03
In a 2019 cohort study, persistent depressive symptoms in older adults increased mortality risk by 2.1x
Interpretation
Health Outcomes Interpretation
Across health outcomes for the elderly, depression is linked to notably worse results, including a 1.7x higher risk of stroke, a 1.5x higher risk of frailty, and a 2.1x higher mortality risk when depressive symptoms persist.
report visual · Key figures
Prevalence of Depression in Older Adults (Selected Studies)
Estimates vary by measurement approach and geography, but late-life depression is consistently reported as a substantial burden among older adults worldwide and in the U.S./Europe.
9.7%
9.7% point prevalence of depression among people aged 60+ in a 2019 WHO-supported multi-country study using ICD-based me
1
Globally, an estimated 1 in 8 adults aged 60+ has a mental disorder (including depression) in a 2021 WHO fact sheet
17.4%
17.4% prevalence of depression among older adults in Europe (estimate) reported in a 2019 systematic review
13.3%
13.3% prevalence of depressive symptoms among older adults worldwide (estimate) reported in a 2020 systematic review/met
source-verifiedapps.who.int · who.int · ncbi.nlm.nih.gov2021
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Marie Larsen. (2026, February 13). Depression In Elderly Statistics. Gitnux. https://gitnux.org/depression-in-elderly-statistics
MLA
Marie Larsen. "Depression In Elderly Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/depression-in-elderly-statistics.
Chicago
Marie Larsen. 2026. "Depression In Elderly Statistics." Gitnux. https://gitnux.org/depression-in-elderly-statistics.
Sources & references
41 datasets cited across this report · attribution is report-level
+31 additional datasets cited (not shown individually)